Skip to main content
. 2017 Jun 20;14(2):2559–2565. doi: 10.3892/ol.2017.6426

Figure 4.

Figure 4.

miR-452 inhibits the migration and invasion abilities of breast cancer cells. (A) Transwell migration and (B) Transwell invasion assays were performed to investigate the effects of miR-452 on MCF-7 and MDA-MB-231 breast cancer cells, revealing reduced migration and invasion capabilities in miR-452 mimic-transfected cells. Data are presented as the mean ± standard deviation. *P<0.05 vs. corresponding miR-NC group. miR-452, microRNA-452; miR-NC, negative control microRNA.